Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2014 1
2015 4
2016 2
2017 2
2018 2
2019 3
2021 2
2022 2
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
CR5/CCL5 axis is linked to a poor outcome, and inhibition reduces metastasis in oral squamous cell carcinoma.
González-Arriagada WA, Coletta RD, Lozano-Burgos C, García C, Maripillán J, Alcayaga-Miranda F, Godínez-Pacheco B, Oyarce-Pezoa S, Martínez-Flores R, García IE. González-Arriagada WA, et al. Among authors: alcayaga miranda f. J Cancer Res Clin Oncol. 2023 Dec;149(19):17335-17346. doi: 10.1007/s00432-023-05443-1. Epub 2023 Oct 13. J Cancer Res Clin Oncol. 2023. PMID: 37831273
Safety and efficacy of clinical-grade, cryopreserved menstrual blood mesenchymal stromal cells in experimental acute respiratory distress syndrome.
Alcayaga-Miranda F, Dutra Silva J, Parada N, Andrade da Silva LH, Ferreira Cruz F, Utreras Y, Hidalgo Y, Cádiz MI, Tapia Limonchi R, Espinoza F, Bruhn A, Khoury M, R M Rocco P, Cuenca J. Alcayaga-Miranda F, et al. Front Cell Dev Biol. 2023 Jan 30;11:1031331. doi: 10.3389/fcell.2023.1031331. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 36793446 Free PMC article.
CD49b Targeting Inhibits Tumor Growth and Boosts Anti-tumor Immunity.
Contreras-Kallens P, Gálvez-Jirón F, De Solminihac J, Elhusseiny A, González-Arriagada WA, Alcayaga-Miranda F, Noelle RJ, Pino-Lagos K. Contreras-Kallens P, et al. Among authors: alcayaga miranda f. Front Oncol. 2022 Jul 4;12:928498. doi: 10.3389/fonc.2022.928498. eCollection 2022. Front Oncol. 2022. PMID: 35860556 Free PMC article.
A Chemically Defined, Xeno- and Blood-Free Culture Medium Sustains Increased Production of Small Extracellular Vesicles From Mesenchymal Stem Cells.
Figueroa-Valdés AI, de la Fuente C, Hidalgo Y, Vega-Letter AM, Tapia-Limonchi R, Khoury M, Alcayaga-Miranda F. Figueroa-Valdés AI, et al. Among authors: alcayaga miranda f. Front Bioeng Biotechnol. 2021 May 26;9:619930. doi: 10.3389/fbioe.2021.619930. eCollection 2021. Front Bioeng Biotechnol. 2021. PMID: 34124014 Free PMC article.
Exosomes on the border of species and kingdom intercommunication.
Schuh CMAP, Cuenca J, Alcayaga-Miranda F, Khoury M. Schuh CMAP, et al. Among authors: alcayaga miranda f. Transl Res. 2019 Aug;210:80-98. doi: 10.1016/j.trsl.2019.03.008. Epub 2019 Mar 29. Transl Res. 2019. PMID: 30998903 Review.
Umbilical Cord-Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II Trial.
Matas J, Orrego M, Amenabar D, Infante C, Tapia-Limonchi R, Cadiz MI, Alcayaga-Miranda F, González PL, Muse E, Khoury M, Figueroa FE, Espinoza F. Matas J, et al. Among authors: alcayaga miranda f. Stem Cells Transl Med. 2019 Mar;8(3):215-224. doi: 10.1002/sctm.18-0053. Epub 2018 Dec 28. Stem Cells Transl Med. 2019. PMID: 30592390 Free PMC article. Clinical Trial.
20 results